This is a delivery order awarded by the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,650.00, is for the procurement of the Arthrex ACP Double Syringe System. It has a period of performance from October 7, 2024, to October 10, 2024. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The contract does not have a set-aside designation, indicating Arthrex's competitive position in the open market for federal contracts. Arthrex also holds a significant Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs (VA), valued at $471,048,172.66, which allows VA medical centers nationwide to acquire Arthrex's innovative joint replacement and implant technologies on an as-needed basis through task orders.
Generated 1/6/25, 12:32 PM